4//SEC Filing
Ginocchio Paul 4
Accession 0001213900-24-044880
CIK 0001769804other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 9:00 PM ET
Size
9.5 KB
Accession
0001213900-24-044880
Insider Transaction Report
Form 4
Augmedix, Inc.AUGX
Ginocchio Paul
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-15+6,250→ 134,250 total - Sale
Common Stock
2024-05-15$1.19/sh−2,354$2,801→ 131,896 total - Exercise/Conversion
Restricted Stock Units
2024-05-15−6,250→ 93,750 total→ Common Stock (6,250 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]Represents an original award of 100,000 RSUs to acquire shares of the Company's common stock. The RSU was granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 02/15/2024, with the first one-sixteenth (1/16th) vesting on 5/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Augmedix, Inc.
CIK 0001769804
Entity typeother
Related Parties
1- filerCIK 0001826036
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 9:00 PM ET
- Size
- 9.5 KB